PerkinElmer
check quantity

CulturPlate-384, White Opaque 384-well Microplate, Sterile and Tissue Culture Treated, Case of 50

384-well white tissue culture-treated (TC-treated) sterile microplate for cell-based assays

Item(s) added to cart.

Part Number
Unit Size
List Price
Your Price
Quantity
6007680
Case of 50
390.00 USD
more
6007688
Case of 160
1187.00 USD
more
6007689
Case of 200
1136.00 USD
more
Buy Now

Please enter valid quantity

Please log in to add favorites.

NULL OR EMPTY CART

Detail Information

The CulturPlate is PerkinElmer's microplate designed for cellular assays, tissue-culture treated and sterilized by gamma-irradiation to facilitate adherent cell growth. The optimized well design and high quality plastics provides low background and crosstalk.

CulturPlates are uniquely engineered to be the same height for 96-, 384-, and 1536-well plates, and with extraordinary well flatness for ease in automation.

Leveraging years of assay and instrument experience in plate detection, PerkinElmer designs better Microplates for better performance that guarantees better results for all PerkinElmer applications.

Specifications

Automation Compatible Yes
Coating Treatment TC-treated, Sterile
Color White
Detection Method Time-Resolved Fluorescence (TRF), Luminescence, Alpha, Radiometric
Material Polystyrene
Product Brand Name CulturPlate
Shipping Condition Ambient
Sterile Yes
Unit Size Case of 50
Wells Number 384 well plate
Resources, Events & More
  • All

Application Note

Measuring PD-L1 and PD-1 Expression in Human Cells with LANCE Ultra TR-FRET

Immuno-oncology is an exciting area within cancer research and among the most promising approaches to activating therapeutic antitumor immunity is through the blockade of immune checkpoints. The programmed cell death-1 (PD-1) immune checkpoint pathway is a negative regulator of T cell immune function. When PD-1 is bound to programmed cell death-ligand 1 (PD-L1), T cell response is suppressed. Many tumor cells escape anti-tumor immunity through their expression of Programmed Death Ligand 1 (PD-L1 or B7-H1), which interacts with T cell-expressed PD-1 and results in T cell apoptosis. PD-L1 expression has been studied in multiple different cancers. While several anti-PD-1 or PD-L1 monoclonal antibodies that block the PD-1/ PD-L1 complex formation have been developed to date, there remains a need for more robust, rapid, high-throughput assays to identify and qualify novel inhibitors of PD-1/PD-L1 binding and assays to detect expression levels of both binding partners. Find out how LANCE® Ultra Technology provides a fast, powerful, homogeneous platform for identifying and characterizing endogenous PD-L1 and PD-1 expression in human cells.

PDF 4 MB

Poster

High Sensitivity cAMP Assays in Primary Cells and Mesenchymal Stem Cells with the LANCE® Ultra cAMP kit

Poster on High Sensitivity cAMP Assays in Primary Cells and Mesenchymal Stem Cells with the LANCE® Ultra cAMP kit

PDF 114 KB